ProfileGDS4459 / ENSG00000143845
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 22% 49% 48% 63% 93% 64% 75% 65% 58% 77% 48% 68% 37% 19% 89% 38% 28% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.4522
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.3749
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.2948
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.9463
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.8593
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.9764
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.7775
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.0365
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.7158
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.8677
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.2348
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.368
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.9237
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.419
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.2889
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.0238
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.6528